ArticleMolecular biology reports2025
Impact of genetic variants in the MMP and ADAM genes towards chronic obstructive pulmonary disease susceptibility and lung function in the North Indian population.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Role of theInternational journal of molecular sciences · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND-: Chronic Obstructive (COPD)pulmonary disease is a significant global health concern, increasingly linked to genetic factors. Airway remodelling in COPD is associated with ADAM33 and MMPs. METHODS-: This study selected SNPs in the protease pathway to evaluate their impact on COPD. A total of 1000 subjects (500 COPD cases and 500 controls) were recruited. Logistic regression calculated odds ratios (ORs) to assess the association between SNPs and COPD risk, and haplotype analysis was performed. SNP interactions were evaluated using Multifactor Dimensionality (MDR) Reduction, and CART analysis identified high-risk subgroups. RESULTS-: Results indicated a strong association between COPD and MMP9 rs17576 (OR = 2.01, Pc = 0.0012) and ADAM33 rs2280091 (OR = 1.80, Pc = 0.0012). SNP combinations highlighted the significance of rs17576, rs2280091, and rs612709 in increasing COPD risk. MMP9 (rs17576) (Pc = 0.003) and ADAM33 (rs2280091) (Pc = 0.0054) are linked to disease severity and mucus production, respectively. Haplotype analysis showed a single change in rs17576 and rs2280091 SNPs increases COPD risk. MDR and CART analysis confirmed these results, indicating rs3918392, rs17576, rs2280091, and rs3918396 are strongly associated with COPD risk (p < 0.0001). CONCLUSION-: The study concludes that rs3918392, rs17576, rs2280091, rs612709, and rs3918396 are linked to COPD risk in the north Indian population, potentially aiding earlier detection, treatment, and prevention.
Indexed as
Identifiers
40512272What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.